These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1312118)

  • 21. Brefeldin A and monensin arrest cell surface expression of membrane glycoproteins and release of rubella virus.
    Qiu Z; Tufaro F; Gillam S
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():855-63. PubMed ID: 9049331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Impact of modification of cleavage site of fusion protein and foreign gene insertion on the virulence of Newcastle Disease Virus LaSota vaccine strain].
    Wang Y; Ge J; Xie X; Ding Y; Bu Z
    Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):362-8. PubMed ID: 18479064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide.
    Paterson RG; Shaughnessy MA; Lamb RA
    J Virol; 1989 Mar; 63(3):1293-301. PubMed ID: 2644448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein.
    Pager CT; Dutch RE
    J Virol; 2005 Oct; 79(20):12714-20. PubMed ID: 16188974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-level expression of the prohormones proenkephalin, pro-neuropeptide Y, proopiomelanocortin, and beta-protachykinin for in vitro prohormone processing.
    Hook VY; Moran K; Kannan R; Kohn A; Lively MO; Azaryan A; Schiller M; Miller K
    Protein Expr Purif; 1997 Jun; 10(1):80-8. PubMed ID: 9179294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A host range mutant of Newcastle disease virus with an altered cleavage site for proteolytic activation of the F protein.
    Pritzer E; Kuroda K; Garten W; Nagai Y; Klenk HD
    Virus Res; 1990 Mar; 15(3):237-42. PubMed ID: 2188464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleotide sequence of the gene encoding the fusion glycoprotein of Newcastle disease virus.
    Chambers P; Millar NS; Emmerson PT
    J Gen Virol; 1986 Dec; 67 ( Pt 12)():2685-94. PubMed ID: 3025345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human parainfluenza virus 3 field strains undergo extracellular fusion protein cleavage to activate entry.
    Stearns K; Lampe G; Hanan R; Marcink T; Niewiesk S; Sternberg SH; Greninger AL; Porotto M; Moscona A
    mBio; 2024 Nov; 15(11):e0232724. PubMed ID: 39382296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA.
    Löber C; Anheier B; Lindow S; Klenk HD; Feldmann H
    Virology; 2001 Oct; 289(2):224-9. PubMed ID: 11689045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium depletion blocks proteolytic cleavages of plasma protein precursors which occur at the Golgi and/or trans-Golgi network. Possible involvement of Ca(2+)-dependent Golgi endoproteases.
    Oda K
    J Biol Chem; 1992 Aug; 267(24):17465-71. PubMed ID: 1324939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus.
    Tashiro M; James I; Karri S; Wahn K; Tobita K; Klenk HD; Rott R; Seto JT
    Virology; 1991 Sep; 184(1):227-34. PubMed ID: 1651590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Processing of Japanese encephalitis virus non-structural proteins: NS2B-NS3 complex and heterologous proteases.
    Jan LR; Yang CS; Trent DW; Falgout B; Lai CJ
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():573-80. PubMed ID: 7897348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160.
    Hallenberger S; Bosch V; Angliker H; Shaw E; Klenk HD; Garten W
    Nature; 1992 Nov; 360(6402):358-61. PubMed ID: 1360148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of paramyxovirus membrane fusion and virus entry.
    Jardetzky TS; Lamb RA
    Curr Opin Virol; 2014 Apr; 5():24-33. PubMed ID: 24530984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mutant CHO-K1 strain with resistance to Pseudomonas exotoxin A is unable to process the precursor fusion glycoprotein of Newcastle disease virus.
    Inocencio NM; Moehring JM; Moehring TJ
    J Virol; 1993 Jan; 67(1):593-5. PubMed ID: 8416387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracellular processing of the Newcastle disease virus fusion glycoprotein.
    Morrison T; Ward LJ; Semerjian A
    J Virol; 1985 Mar; 53(3):851-7. PubMed ID: 3838349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. F0-containing noninfectious Sendai virus can initiate replication in mouse lungs but requires a relatively long incubation period.
    Kiyotani K; Sakaguchi T; Fujii Y; Yoshida T
    J Virol; 1993 Dec; 67(12):7618-22. PubMed ID: 7693976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virus activation by host proteinases. A pivotal role in the spread of infection, tissue tropism and pathogenicity.
    Nagai Y
    Microbiol Immunol; 1995; 39(1):1-9. PubMed ID: 7783672
    [No Abstract]   [Full Text] [Related]  

  • 39. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus.
    Nagai Y; Klenk HD; Rott R
    Virology; 1976 Jul; 72(2):494-508. PubMed ID: 948870
    [No Abstract]   [Full Text] [Related]  

  • 40. Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium.
    Tashiro M; Yamakawa M; Tobita K; Klenk HD; Rott R; Seto JT
    J Virol; 1990 Aug; 64(8):3627-34. PubMed ID: 2164589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.